Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers

NCT01530464 is registered in ClinicalTrials.gov with Thies Schroeder as lead sponsor.

NCT NCT01530464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01530464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers
Lead sponsor
Thies Schroeder
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2012
Completion date
April 30, 2012
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high altitude pulmonary hypertension